Rigaku Partners with SPERA PHARMA to Boost Pharmaceutical Development
Rigaku Corporation, a Group company of Rigaku Holdings Corporation, and SPERA PHARMA, Inc. (headquarters: Osaka; President & Representative Director: Keitaro Iwaki; hereinafter “SPERA PHARMA”) have initiated a strategic partnership aimed at accelerating and transforming pharmaceutical development by leveraging the two companies’ cutting-edge technologies and extensive expertise. SPERA PHARMA will use XtaLAB Synergy-ED, an integrated platform […]
